Latest Content

  • Interactive eBook: Advanced RWE Learnings from the Field

    Interactive eBook: Advanced RWE Learnings from the Field

    This interactive ebook looks how you can create a strategy to prove your therapy’s value and get prescribers and payers onboard.

    Read More
  • Plan & Engage Early To Manage the Risks of Risk Management

    Plan & Engage Early To Manage the Risks of Risk Management

    View Now
  • ×

    Tell Us About Your Market Access Nightmares.

    What keeps you up at night?
    Thank you!
    Error - something went wrong!
  • Real-World Data's Impact on Clinical Research4:27

    Real-World Data's Impact on Clinical Research

    Integrating Real-World Data into clinical research is revolutionizing the life sciences industry. Learn more in this portion of 'The Innovation Imperative: The Future of Drug Development,' an independ

    Watch Video
  • Download the latest posters from ISPOR EU, 2018

    Get Poster ►
  • Get your free evidence readiness score today!

    Take Assessment
  • Time-Limited G-BA Resolutions3:36

    Time-Limited G-BA Resolutions

    Description

    Watch Video
  • ×

    Speak to one of our experts today

    First Name
    Last Name
    Company Name
    Title
    Country
    Comments
    We'll be in touch shortly!
    Error - something went wrong!
  • Real World Evidence: Does The Popularity Of The Term Reflect In Publication numbers?5:35

    Real World Evidence: Does The Popularity Of The Term Reflect In Publication numbers?

    Description

    Watch Video
  • Pan European HTA - Where we have been, where we are going?9:27

    Pan European HTA - Where we have been, where we are going?

    Description

    Watch Video
  • Explore the latest updates in Pricing & Reimbursement

    Click Here
  • Moving From The Regulator To The Payer And Prescriber4:31

    Moving From The Regulator To The Payer And Prescriber

    Description

    Watch Video
  • Classification Of Cell And Gene Therapies2:43

    Classification Of Cell And Gene Therapies

    How classification of cell and gene therapies as drugs, devices or procedures could have significant implications for their pricing and reimbursement, and commercial success.

    Watch Video
  • Has the NICE HST process been a success? Comparison with other European bodies3:54

    Has the NICE HST process been a success? Comparison with other European bodies

    Description

    Watch Video
  • Assess The Strength Of Your Evidence Strategy2:00

    Assess The Strength Of Your Evidence Strategy

    See how the Evidence Wisely Assessment Tool can help you assess your readiness for market access. Fenerate your own unique score and assess strengths and weaknesses of your value demonstration strateg

    Watch Video
  • Communicating Product Value for Success: Every Word Counts

    Communicating Product Value for Success: Every Word Counts

    Read More
  • Internal Collaboration is a Prerequisite for Improved Value Communications

    Internal Collaboration is a Prerequisite for Improved Value Communications

    Read More
  • Effective use of Value to Achieve Optimal Market Access

    Effective use of Value to Achieve Optimal Market Access

    Read this presentation to find out more!

    Read More
  • Orphan Drug Pricing in Europe

    Orphan Drug Pricing in Europe

    Read this presentation to find out more!

    Read More
  • The Evolution of Drug Development & Market Access via Connected Data-driven Solutions

    The Evolution of Drug Development & Market Access via Connected Data-driven Solutions

    Read this presentation to find out more!

    Read More
  • Three Ways to Mitigate the Risk of Late-stage Failure in CNS Drug Development

    Three Ways to Mitigate the Risk of Late-stage Failure in CNS Drug Development

    Read this presentation to find out more!

    Read More
  • loading
    Loading More...